Dietary quercetin supplementation in mice increases skeletal muscle PGC1α expression, improves mitochondrial function and attenuates insulin resistance in a time-specific manner

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Henagan, Tara M ^a   Lenard, Natalie R ^b   Gettys, Thomas W ^c   Stewart, Laura K ^d  

^a PURDUE UNIVERSITY   (United States)

^b Our Lady of the Lake College   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; QUERCETIN; INSULIN; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BODY WEIGHT; CALORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE TOLERANCE TEST; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LUNG GAS EXCHANGE; MALE; METABOLOMICS; MITOCHONDRION; MOUSE; NONHUMAN; PHENOTYPE; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA DEGRADATION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; MUSCLE MITOCHONDRION; PHYSIOLOGY; TIME;

ANIMALS; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; QUERCETIN; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84896774151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089365     Document Type: Article

References (40)

1. Bournat JC, Brown CW (2010) Mitochondrial dysfunction in obesity. Current Opinion in Endocrinology, Diabetes and Obesity 17: 446-452 410.1097/MED. 1090b1013e32833c33026.
2. Højlund K, Mogensen M, Sahlin K, Beck-Nielsen H (2008) Mitochondrial Dysfunction in Type 2 Diabetes and Obesity. Endocrinology & Metabolism Clinics of North America 37: 713-731.
3. Kim JA, Wei Y, Sowers JR (2008) Role of mitochondrial dysfunction in insulin resistance. Circ Res 102: 401-414. (Pubitemid 351651099)
4. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. (2008) Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance. Cell Metabolism 7: 45-56.
5. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, et al. (1991) Development of muscle insulin resistance after liver insulin resistance in high-fatfed rats. Diabetes 40: 1397-1403.
6. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, et al. (2007) Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity. Journal of Biological Chemistry 282: 15439-15450.
7. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, et al. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. Embo J 26: 1913-1923. (Pubitemid 46624046)
8. Koves TR, Li P, An J, Akimoto T, Slentz D, et al. (2005) Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem 280: 33588-33598. (Pubitemid 41397160)
9. Knutti D, Kralli A (2001) PGC-1, a versatile coactivator. Trends in Endocrinology & Metabolism 12: 360-365. (Pubitemid 33714230)
10. Liang H, Ward WF (2006) PGC-1α: a key regulator of energy metabolism. Advances in Physiology Education 30: 145-151. (Pubitemid 44749372)
11. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, et al. (1999) Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1. Cell 98: 115-124. (Pubitemid 29331201)
12. Lin J, Wu H, Tarr PT, Zhang C-Y, Wu Z, et al. (2002) Transcriptional co-activator PGC-1[alpha] drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
13. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, et al. (2005) A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54: 1926-1933. (Pubitemid 40911253)
14. Anhe GF, Okamoto MM, Kinote A, Sollon C, Lellis-Santos C, et al. (2012) Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. Eur J Pharmacol 689: 285-293.
15. Davis JM, Murphy EA, Carmichael MD, Davis B (2009) Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 296: R1071-1077.
16. Jeong SM, Kang MJ, Choi HN, Kim JH, Kim JI (2012) Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract 6: 201-207.
17. Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M (2008) Quercetin Ameliorates Metabolic Syndrome and Improves the Inflammatory Status in Obese Zucker Rats. Obesity 16: 2081-2087.
18. Davis JM, Murphy EA, Carmichael MD, Davis B (2009) Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 296: R1071-R1077.
19. Stewart L, Wang Z, Ribnicky D, Soileau J, Cefalu W, et al. (2009) Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity. Diabetologia 52: 514-523.
20. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J (1999) Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26: 107-116.
21. Watjen W, Michels G, Steffan B, Niering P, Chovolou Y, et al. (2005) Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. J Nutr 135: 525-531. (Pubitemid 40365213)
22. Ortega R, García N (2009) The flavonoid quercetin induces changes in mitochondrial permeability by inhibiting adenine nucleotide translocase. Journal of Bioenergetics and Biomembranes 41: 41-47.
23. Vessal M, Hemmati M, Vasei M (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 135C: 357-364. (Pubitemid 36962949)
24. Jeong S-M, Kang M-J, Choi H-N, Kim J-H, Kim J-I (2012) Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract 6: 201-207.
25. Anhê GF, Okamoto MM, Kinote A, Sollon C, Lellis-Santos C, et al. (2012) Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. European Journal of Pharmacology 689: 285-293.
26. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, et al. (2001) Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine 344: 1343-1350. (Pubitemid 32378388)
27. Schrauwen P (2007) High-fat diet, muscular lipotoxicity and insulin resistance. Proceedings of the Nutrition Society 66: 33-41.
28. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, et al. (2007) Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle: Evidence Against a Role for Reduced Fatty Acid Oxidation in Lipid-Induced Insulin Resistance in Rodents. Diabetes 56: 2085-2092. (Pubitemid 47195821)
29. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, et al. (2007) Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity: Potential pathogenic role of saturated fatty acids and p38 mitogen porein kinase activation. Journal of Biological Chemistry 282: 15439-15450. (Pubitemid 47093279)
30. Park SY, Cho YR, Kim HJ, Higashimori T, Danton C, et al. (2005) Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54: 3530-3540. (Pubitemid 43334346)
31. Arany Z, He H, Lin J, Hoyer K, Handschin C, et al. (2005) Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle. Cell Metabolism 1: 259-271. (Pubitemid 43960608)
32. Lin J, Wu P-H, Tarr PT, Lindenberg KS, St-Pierre J, et al. (2004) Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice. Cell 119: 121-135. (Pubitemid 39349325)
33. Vidyashankar S, Sandeep Varma R, Patki PS (2013) Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. Toxicology in Vitro 27: 945-953.
34. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, et al. (2010) Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity. Obesity 18: 1695-1700.
35. Liang H, Balas B, Tantiwong P, Dube J, Goodpaster BH, et al. (2009) Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity. American Journal of Physiology - Endocrinology And Metabolism 296: E945-E954.
36. Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, et al. (2011) Exercise Increases Mitochondrial PGC-1α Content and Promotes Nuclear-Mitochondrial Cross-talk to Coordinate Mitochondrial Biogenesis. Journal of Biological Chemistry 286: 10605-10617.
37. Muoio DM, Koves TR (2007) Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found Symp 286: 24-38; discussion 38-46, 162-163, 196-203.
38. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, et al. (2009) Metabolomics Applied to Diabetes Research. Diabetes 58: 2429-2443.
39. Makowski L, Noland RC, Koves TR, Xing W, Ilkayeva OR, et al. (2009) Metabolic profiling of PPARα-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. The FASEB Journal 23: 586-604.
40. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, et al. (2010) Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women. PLoS ONE 5: e15234. Medicine